Provincial Specialist Hospital Them. J. Gromkowski
- Address
- Ul. Koszarowa 5, 51-149 Wroclaw, Poland
Provincial Specialist Hospital Them. J. Gromkowski - Epilepsy and Neurological Emergency Care
Provincial Specialist Hospital Them. J. Gromkowski is a specialized medical institution engaged in advanced clinical research focused on critical neurological conditions. The center demonstrates particular expertise in managing acute seizure disorders and neurological emergencies, contributing to the development of innovative therapeutic approaches for patients with life-threatening epileptic conditions.
- Refractory Status Epilepticus treatment and management
- Novel antiepileptic drug development and evaluation
- Emergency neurological care and critical seizure intervention
The hospital's research program emphasizes pharmacological interventions for treatment-resistant seizures, investigating the efficacy and safety profiles of investigational medications when combined with standard therapeutic protocols. Through participation in double-blind, placebo-controlled trials, the center contributes valuable data on adjunctive intravenous therapies for patients who have not responded adequately to conventional antiepileptic drugs, advancing the field of emergency neurology and critical care epileptology.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1CSL Behring LLC1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Provincial Specialist Hospital Them. J. Gromkowski
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A double-blind, randomized, placebo-controlled study to evaluate the efficacy, safety, and tolerability of intravenous ganaxolone added to standard of care in refractory status epilepticus | Marinus Pharmaceuticals Inc. | Phase III | Not Recruiting | Nov 2023 | Apr 2024 |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Clostridium Botulinum, Neurotoxin Serotype A/B | 1 | Unknown | 2025-06-17 | 2025-06-17 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.